ASCL2 and cancer: These results suggested that overexpression of ASCL2 in CRC cells could also be confirmed their ability to self-renew, and their proliferative ability does not change, consistent with the fact that LGR5+ cancer stem cells depletion did not lead to tumor regression [32].